Lilly Urges High Court To Review Its $20M Cialis Patent Loss
Eli Lilly has taken its $20 million loss to a "shadowy non-practicing entity" to the Supreme Court, telling the justices a lower court's ruling that it infringed a patent when marketing...To view the full article, register now.
Already a subscriber? Click here to view full article